A pharmacokinetic and endocrine comparison of recombinant follicle-stimulating hormone and human menopausal gonadotrophin in polycystic ovary syndrome

Reproductive BioMedicine Online

Volumn 6, Issue 3, 2003, Pages 296-301

  Balasch, Juan ^a   Fabregues F ^a   Casamitjana, R ^a   Penarrubia J ^a   Vanrell, J A ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

FSH; LH; LH urine concetrations; Ovulation induction; PCOS

Indexed keywords

ANDROSTENEDIONE; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; ESTRADIOL; FOLLITROPIN; HUMAN MENOPAUSAL GONADOTROPIN; INHIBIN A; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT FOLLITROPIN; TESTOSTERONE;

ADULT; ANDROSTENEDIONE BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HORMONE DETERMINATION; HORMONE URINE LEVEL; HUMAN; KIDNEY TUBULE EXCRETION; LOW DRUG DOSE; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PROGESTERONE BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; URINALYSIS;

EID: 0038575303     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)61848-2     Document Type: Article

References (35)

1. ACOG Practice Bulletin 2002 Management of infertility caused by ovulatory dysfunction. Obstetrics and Gynecology 99, 347-358.
2. Adams J, Polson DW, Franks S 1986 Prevalence of polycystic ovaries in women with anovulation or idiopathic hirsutism. British Medical Journal 293, 355-359.
3. Amer SAKS, Banu Z, Li TC, Cooke ID 2002 Long-term follow-up of patients with polycystic ovary syndrome after laparoscopic ovarian drilling: endocrine and ultrasonographic outcomes. Human Reproduction 17, 2851-2857.
4. Anderson RE, Cragun JM, Chang RJ et al. 1989 A pharmacodynamic comparison of human urinary follicle-stimulating hormone and human menopausal gonadotropin in normal women and polycystic ovary syndrome. Fertility and Sterility 52, 216-220.
5. Balasch J, Fábregues F, Creus M et al. 2001a Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome: prospective, randomized comparison between low-dose step-up and modified step-down regimens. Human Reproduction 16, 652-656.
6. Balasch J, Fábregues F, Peñarrubia J et al. 1998 Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women and WHO group II anovulatory infertile patients. Journal of Assisted Reproduction Genetics 15, 552-559.
7. Balasch J, Vidal E, Peñarrubia J et al. 2001b Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH. Human Reproduction 16, 1636-1643.
8. Bergendahl M, Evans WS, Veldhuis JD 1996 Current concepts on ultradian rhythms of luteinizing hormone secretion in the human. Human Reproduction Update 2, 507-518.
9. Clifford K, Rai R, Watson H, Regan L 1994 An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Human Reproduction 9, 1328-1332.
10. Creus M, Ordi J, Fábregues, F et al. 2001 Mid-luteal serum inhibin-A concentration as a marker of endometrial differentiation. Human Reproduction 16, 1347-1352.
11. Fauser BCJM, van Heusden AM 1997 Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocrine Reviews 18, 71-106.
12. Filicori M 1999 The role of luteinizing hormone in folliculogenesis and ovulation induction. Fertility and Sterility 71, 405-414.
13. Filicori M, Cognigni GE, Taraborrelli S et al. 2001 Luteinizing hormone activity in menotropins optimizes folliculogenesis and treatment in controlled ovarian stimulation. Journal of Clinical Endocrinology and Metabolism 86, 337-343.
14. Fleming R, Rehka P, Deshpande N et al. 2000 Suppression of LH during ovarian stimulation: effects differ in cycles stimulated with purified urinary FSH and recombinant FSH. Human Reproduction 15, 1440-1445.
15. Giudice E, Crisci C, Altarocca V, O'Brien MO 2001 Characterisation of a partially purified human menopausal gonadotropin preparation. Journal of Clinical Research 4, 27-34.
16. Hamilton-Fairley D, Kiddy D, Watson H et al. 1991 Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome. Human Reproduction 6, 1095-1099.
17. Hillier SG 1994 Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Human Reproduction 9, 188-191.
18. Homburg R 1998 Adverse effects of luteinizing hormone on fertility: fact or fantasy. Baillière's Clinical Obstetrics and Gynaecology 12, 555-563.
19. Lambert A, Talbot JA, Anobile CJ, Robertson WR 1998 Gonadotrophin heterogeneity and biopotency: implications for assisted reproduction. Molecular Human Reproduction 4, 619-629.
20. Larsen T, Larsen JF, Schioler V et al. 1990 Comparison of urinary human follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in polycystic ovarian syndrome. Fertility and Sterility 53, 426-431.
21. le Cotonnec JY, Porchet HC, Beltrami V et al. 1994 Clinical pharmacology of recombinant human follicle-stimulating hormone (FSH). I. Comparative pharmacokinetics with urinary human FSH. Fertility and Sterility 61, 669-678.
22. le Cotonnec JY, Porchet HC, Beltrami V, Munafo A 1998 Clinical pharmacology of recombinant human luteinizing hormone: Part I. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with urinary human luteinizing hormone. Fertility and Sterility 69, 189-194.
23. Li TC, Spuijbroek MDEH, Tuckerman E et al. 2000 Endocrinological and endometrial factors in recurrent miscarriage. British Journal of Obstetrics and Gynaecology 107, 1471-1479.
24. Rodgers M, McLoughlin J, Peer N et al. 1994 Accumulation of human chorionic gonadotrophin in the serum patients during in-vitro fertilization cycles with Pergonal. Human Reproduction 9, 638-642.
25. Rose MP, Das REG, Balen AH 2000 Definition and measurement of follicle stimulating hormone. Endocrine Reviews 21, 5-22.
26. Sagle MA, Hamilton-Fairley D, Kiddy DS, Franks S 1991 A comparative, randomized study of low-dose human menopausal gonadotropin and follicle-stimulating hormone in women with polycystic ovarian syndrome. Fertility and Sterility 55, 56-60.
27. Shoham Z, Jacobs HS, Insler V 1993 Luteinizing hormone: its role, mechanism of action, and detrimental effects when hypersecreted during the follicular phase. Fertility and Sterility 59, 1153-1161.
28. Simoni M, Nieschlag E 1995 FSH in therapy: physiological basis, new preparations and clinical use. Reproductive Medicine Review 4, 163-177.
29. Stanton PG, Burgon PG, Hearn MT, Robertson DM 1996 Structural and functional characterisation of hFSH and hLH isoforms. Molecular and Cellular Endocrinology 125, 133-141.
30. Teissier MP, Chable H, Paulhac S, Aubard Y 1999 Recombinant human follicle stimulating hormone versus human menopausal gonadotrophin induction: effects in mature follicle endocrinology. Human Reproduction 14, 2236-2241.
31. Thomas A, Okamoto S, O'Shea F et al. 1989 Do raised serum luteinizing hormone levels during stimulation for in-vitro fertilization predict outcome? British Journal of Obstetrics and Gynaecology 96, 1328-1332.
32. Walton WJ, Nguyen VT, Butnev VY et al. 2001 Characterization of human FSH isoforms reveals a nonglycosylated β-subunit in addition to the conventional glycosylated β-subunit. Journal of Clinical Endocrinology and Metabolism 86, 3675-3685.
33. Watson H, Kiddy DS, Hamilton-Fairley D et al. 1993 Hypersecretion of luteinizing hormone and ovarian steroids in women with recurrent early miscarriage. Human Reproduction 8, 829-833.
34. Westergaard LG, Laursen SB, Andersen YC 2000 Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Human Reproduction 15, 1003-1008.
35. White D, Mason HD, Franks S 1991 24 hour pattern of LH secretion of ovulating women with polycystic ovaries: evidence for normal hypothalamic regulation of LH. Proceedings of the Endocrine Society Washington, Abstract 1224.